why choose us

First received: January 05, 2023

Clinical Trial: Evaluation of Safety and Immunogenicity of rVSV?G-SEBOV-GP Vaccine in Adults With Good General Health

Study Status: ACTIVE_NOT_RECRUITING

Recruit Status: ACTIVE_NOT_RECRUITING

Condition: Ebola Sudan Virus Disease

Study Type: INTERVENTIONAL


Official Title: A Phase 1, Single-blind, Placebo-controlled, Dose-escalation Clinical Trial to Evaluate the Safety and Immunogenicity of rVSV?G-SEBOV-GP Vaccine at 3 Dose Levels in Adults in Good General Health

Brief Summary: A Phase 1, Single-blind, Placebo-controlled, Dose-escalation Clinical Trial to Evaluate the Safety and Immunogenicity of rVSV?G-SEBOV-GP Vaccine at 3 Dose Levels in Adults in Good General Health

Read more